BXP
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E 33.18, Graham Number $35.65
- P/E is lower than the sector average of 39.51
- Price is 62% above Graham Number
- Price is 375% above Intrinsic Value
- High PEG ratio (2.24)
Ref Growth rates
- Slight Q/Q revenue growth (2.16%)
- Catastrophic YoY revenue growth (-31.90%)
- Structural decline in office REIT sector
Ref Historical trends
- 3Y change is positive (+35.8%)
- 5Y change is negative (-30.4%)
- Recent 6M trend is sharply bearish (-20.3%)
Ref Piotroski F-Score 4/9
- Piotroski F-Score of 4/9 indicates stability
- Current Ratio < 1.0 (0.92)
- High leverage (Debt/Equity 2.26)
- Recent long-lived asset impairments
Ref Yield 5.34%, Payout 193.10%
- Attractive nominal yield (5.34%)
- Payout ratio of 193.10% is fundamentally unsustainable
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BXP and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BXP
BXP, Inc.
Primary
|
-30.4% | +35.8% | -8.3% | -20.3% | +10.8% | -0.6% |
|
AGNCM
AGNC Investment Corp.
Peer
|
+47.6% | +44.5% | +6.7% | +3.8% | -0.8% | -0.4% |
|
AGNCN
AGNC Investment Corp.
Peer
|
+55.3% | +40.2% | +7.3% | +3.6% | -0.6% | +0.0% |
|
AHR
American Healthcare REIT, Inc.
Peer
|
+278.7% | +278.7% | +65.4% | +25.2% | -4.0% | -3.7% |
|
LINE
Lineage, Inc.
Peer
|
-53.9% | -53.9% | -30.4% | -10.3% | -10.9% | +4.2% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Real Estate Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BXP
BXP, Inc.
|
BEARISH | $9.16B | 33.18 | 4.9% | 8.8% | $57.73 | |
|
AGNCM
AGNC Investment Corp.
|
BEARISH | $8.82B | - | 15.1% | 92.9% | $24.81 | Compare |
|
AGNCN
AGNC Investment Corp.
|
BEARISH | $8.79B | - | 15.1% | 92.9% | $25.6 | Compare |
|
AHR
American Healthcare REIT, Inc.
|
BEARISH | $8.61B | 385.33 | 1.1% | 1.2% | $46.24 | Compare |
|
LINE
Lineage, Inc.
|
BEARISH | $8.56B | - | -1.2% | -1.9% | $34.33 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-27 | SPANN HILARY J. | Officer | Sale | 5,495 | $327,997 |
| 2026-02-25 | SPANN HILARY J. | Officer | Stock Award | 5,495 | - |
| 2026-02-13 | THOMAS OWEN D | Chief Executive Officer | Sale | 1,198 | $73,341 |
| 2026-02-05 | SPANN HILARY J. | Officer | Sale | 1,194 | $75,592 |
| 2026-01-30 | SPANN HILARY J. | Officer | Stock Award | 12,757 | - |
| 2025-12-01 | RITCHEY RAYMOND A | Officer | Sale | 36,314 | $2,621,134 |
| 2025-11-26 | RITCHEY RAYMOND A | Officer | Stock Award | 36,314 | - |
| 2025-11-25 | OTTENI PETER V | Officer | Sale | 4,136 | $300,470 |
| 2025-11-17 | OTTENI PETER V | Officer | Stock Award | 4,136 | - |
| 2025-11-12 | STROMAN JOHN J | Officer | Sale | 16,838 | $1,215,239 |
| 2025-11-07 | LABELLE MICHAEL E. | Chief Financial Officer | Sale | 13,422 | $970,952 |
| 2025-11-06 | KEVORKIAN ERIC G | Officer | Gift | 100 | - |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
BXP is a leading office REIT with a portfolio of 179 commercial properties totaling approximately 52.6 million net rentable square feet across six major US gateway markets. The company faces significant concentration risk, as its revenue is heavily dependent on the economic conditions and demand for premier workplace space in Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. Economic downturns in these specific markets could adversely affect performance through reduced demand and lower rental rates.
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning BXP from our newsroom.